U.D. Drugs Company Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 15-11-2024
- Paid Up Capital ₹ 0.11 M
as on 15-11-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 65.80%
(FY 2023)
- Ebitda 65.80%
(FY 2023)
- Net Worth -4.87%
(FY 2023)
- Total Assets -4.67%
(FY 2023)
About U.D. Drugs Company
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Newatia and Asha Newatia serve as directors at the Company.
- CIN/LLPIN
U74900WB2013PTC198074
- Company No.
198074
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at U.D. Drugs Company?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Newatia  | Director | 24-Oct-2013 | Current |
| Asha Newatia | Additional Director | 13-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of U.D. Drugs Company.
U.D. Drugs Company Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 65.8% increase in profit. The company's net worth dipped by a decrease of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U.D. Drugs Company?
In 2023, U.D. Drugs Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at U.D. Drugs Company?
Unlock and access historical data on people associated with U.D. Drugs Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U.D. Drugs Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U.D. Drugs Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
